loadpatents
name:-0.55399584770203
name:-0.19455099105835
name:-0.008699893951416
HAUSWIRTH; William W. Patent Filings

HAUSWIRTH; William W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for HAUSWIRTH; William W..The latest application filed is for "raav-guanylate cyclase compositions and methods for treating leber's congenital amaurosis-1 (lca1)".

Company Profile
7.21.44
  • HAUSWIRTH; William W. - Gainesville FL
  • Hauswirth; William W - Gainesville FL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Reagents And Methods For Modulating Cone Photoreceptor Activity
App 20220183613 - NEITZ; Jay ;   et al.
2022-06-16
Raav-guanylate Cyclase Compositions And Methods For Treating Leber's Congenital Amaurosis-1 (lca1)
App 20220186260 - Boye; Shannon E. ;   et al.
2022-06-16
Enhanced Human Opsin Promoter For Rod Specific Expression
App 20220175969 - Dyka; Frank M. ;   et al.
2022-06-09
Dual-AAV vector-based systems and methods for delivering oversized genes to mammalian cells
Grant 11,325,956 - Boye , et al. May 10, 2
2022-05-10
Adeno-associated Viral Vectors For The Treatment Of Best Disease
App 20220033826 - Hauswirth; William W. ;   et al.
2022-02-03
A Codon Optimized Otoferlin Aav Dual Vector Gene Therapy
App 20210395778 - Dyka; Frank M. ;   et al.
2021-12-23
Reagents and methods for modulating cone photoreceptor activity
Grant 11,160,488 - Neitz , et al. November 2, 2
2021-11-02
Aav Vectors For Treatment Of Dominant Retinitis Pigmentosa
App 20210324387 - Lewin; Alfred S. ;   et al.
2021-10-21
AAV vectors for treatment of dominant retinitis pigmentosa
Grant 11,118,185 - Lewin , et al. September 14, 2
2021-09-14
Compositions And Methods For Treatment Of Dominant Retinitis Pigmentosa
App 20210207147 - Lewin; Alfred S. ;   et al.
2021-07-08
Dual-aav Vector-based Systems And Methods For Delivering Oversized Genes To Mammalian Cells
App 20210130421 - Boye; Sanford L. ;   et al.
2021-05-06
Compositions And Methods For Expressing Otoferlin
App 20200157573 - Boye; Sanford L. ;   et al.
2020-05-21
rAAV vector compositions, methods for targeting vascular endothelial cells and use in treatment of type I diabetes
Grant 10,648,000 - Hauswirth , et al.
2020-05-12
Methods and compositions for restoration of cone function in BCM
Grant 10,533,187 - Hauswirth , et al. Ja
2020-01-14
Aav-mediated Gene Therapy For Nphp5 Lca-ciliopathy
App 20190343920 - Aguirre; Gustavo ;   et al.
2019-11-14
Capsid-mutated rAAV vectors and methods of use
Grant 10,426,844 - Agbandje-McKenna , et al. October 1, 2
2019-10-01
AAV-mediated gene therapy for RPGR X-linked retinal degeneration
Grant 10,383,922 - Beltran , et al. A
2019-08-20
Dual-aav Vector-based Systems And Methods For Delivering Oversized Genes To Mammalian Cells
App 20190153050 - Boye; Sanford L. ;   et al.
2019-05-23
Aav Vectors For Treatment Of Dominant Retinitis Pigmentosa
App 20190093111 - Lewin; Alfred S. ;   et al.
2019-03-28
Dual-AAV vector-based systems and methods for delivering oversized genes to mammalian cells
Grant 10,214,572 - Boye , et al. Feb
2019-02-26
Reagents And Methods For Modulating Cone Photoreceptor Activity
App 20180344197 - NEITZ; Jay ;   et al.
2018-12-06
Methods And Compositions For Restoration Of Cone Function In Bcm
App 20180112231 - Hauswirth; William W. ;   et al.
2018-04-26
Raav-guanylate Cyclase Compositions And Methods For Treating Leber's Congenital Amaurosis-1 (lca1)
App 20180100165 - Boye; Shannon E. ;   et al.
2018-04-12
Raav Vector Compositions, Methods For Targeting Vascular Endothelial Cells And Use In Treatment Of Type I Diabetes
App 20180057840 - Hauswirth; William W. ;   et al.
2018-03-01
Aav-mediated Gene Therapy For Rpgr X-linked Retinal Degeneration
App 20180036385 - BELTRAN; William A. ;   et al.
2018-02-08
Aav-mediated Gene Therapy For Nphp5 Lca-ciliopathy
App 20170348387 - Aguirre; Gustavo ;   et al.
2017-12-07
rAAV-guanylate cyclase compositions and methods for treating lebers congenital amaurosis-1 (LCA1)
Grant 9,816,108 - Boye , et al. November 14, 2
2017-11-14
AAV-mediated gene therapy for RPGR X-linked retinal degeneration
Grant 9,770,491 - Beltran , et al. September 26, 2
2017-09-26
Methods And Compositions For Gene Delivery To On Bipolar Cells
App 20170007720 - Boye; Shannon E. ;   et al.
2017-01-12
CAPSID-MUTATED rAAV VECTORS AND METHODS OF USE
App 20160361439 - AGBANDJE-MCKENNA; Mavis ;   et al.
2016-12-15
Method of Treating or Retarding the Development of Blindness
App 20160263246 - Acland; Gregory M. ;   et al.
2016-09-15
Method of treating or retarding the development of blindness
Grant 9,433,688 - Acland , et al. September 6, 2
2016-09-06
Chimeric promoter for cone photoreceptor targeted gene therapy
Grant 9,375,491 - Boye , et al. June 28, 2
2016-06-28
Reagents And Methods For Modulating Cone Photoreceptor Activity
App 20160015288 - NEITZ; Jay ;   et al.
2016-01-21
Reagents and methods for modulating cone photoreceptor activity
Grant 9,198,595 - Neitz , et al. December 1, 2
2015-12-01
Aav-mediated Gene Therapy For Rpgr X-linked Retinal Degeneration
App 20150202269 - Beltran; William A ;   et al.
2015-07-23
Method of Treating or Retarding the Development of Blindness
App 20140377224 - Acland; Gregory M. ;   et al.
2014-12-25
Chimeric Promoter For Cone Photoreceptor Targeted Gene Therapy
App 20140275231 - Boye; Sanford Leon ;   et al.
2014-09-18
Dual-AAV Vector-Based Systems and Methods for Delivering Oversized Genes to Mammalian Cells
App 20140256802 - Boye; Sanford Leon ;   et al.
2014-09-11
Reagents And Methods For Modulating Cone Photoreceptor Activity
App 20140080900 - NEITZ; Jay ;   et al.
2014-03-20
Method Of Treating Or Retarding The Development Of Blindness
App 20130216500 - Acland; Gregory M. ;   et al.
2013-08-22
rAAV-Guanylate Cyclase Compositions and Methods for Treating Lebers Congenital Amaurosis-1 (LCA1)
App 20130210895 - Boye; Shannon Elizabeth ;   et al.
2013-08-15
Self-complementary adeno-associated virus having a truncated CMV-chicken .beta.-actin promoter
Grant 8,298,818 - Boye , et al. October 30, 2
2012-10-30
Method Of Treating Or Retarding The Development Of Blindness
App 20120225930 - Acland; Gregory M. ;   et al.
2012-09-06
Small Peptide Expression System in Mammalian Cells
App 20120157513 - Li; Qiuhong ;   et al.
2012-06-21
Method of treating or retarding the development of blindness
Grant 8,147,823 - Acland , et al. April 3, 2
2012-04-03
Method Of Treating Or Retarding The Development Of Blindness
App 20100272688 - Acland; Gregory M. ;   et al.
2010-10-28
Double-stranded/self-complementary Vectors With A Truncated Cba Promoter And Methods Of Gene Delivery
App 20100069467 - Boye; Sanford L. ;   et al.
2010-03-18
Method of Treating or Retarding the Development of Blindness
App 20090074723 - Acland; Gregory M. ;   et al.
2009-03-19
Method of treating or retarding the development of blindness
App 20070077228 - Acland; Gregory M. ;   et al.
2007-04-05
Adeno-associated virus-delivered ribozyme compositions and methods of use
App 20060248604 - Lewin; Alfred S. ;   et al.
2006-11-02
Production of pseudotyped recombinant AAV virions
Grant 7,094,604 - Snyder , et al. August 22, 2
2006-08-22
Raav expression systems and methods for enhancing transduction of mammalian neural cells
App 20060127358 - Muzyczka; Nicholas ;   et al.
2006-06-15
Production of pseudotyped recombinant AAV virions
App 20040209245 - Snyder, Richard O. ;   et al.
2004-10-21
Method of treating or retarding the development of blindness
App 20040022766 - Acland, Gregory M. ;   et al.
2004-02-05
Expression of glial-derived neurotrophic factor for treatment of diseases of the eye
App 20030129164 - Flannery, John G. ;   et al.
2003-07-10
Rod opsin mRNA-specific ribozyme compositions and methods for the treatment of retinal diseases
Grant 6,225,291 - Lewin , et al. May 1, 2
2001-05-01
Humanized green fluorescent protein genes and methods
Grant 5,968,750 - Zolotukhin , et al. October 19, 1
1999-10-19
Humanized green fluorescent protein genes and methods
Grant 5,874,304 - Zolotukhin , et al. February 23, 1
1999-02-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed